New class of cancer drugs could work in colon cancers with genetic mutation

New class of cancer drugs could work in colon cancers with genetic mutation, U-M study finds — 15 percent of colorectal cancers have mutation that responds to PARP inhibitors – A class of drugs that shows promise in breast and ovarian cancers with BRCA gene mutations could potentially benefit colorectal cancer patients with a different genetic mutation, a new study from the University of Michigan Comprehensive Cancer Center finds.

Omega 3 good for heart not for prostate

High percentage of omega-3s in the blood may boost risk of aggressive prostate cancer — Conversely, high percentage of trans-fatty acids linked with lower risk – The largest study ever to examine the association of dietary fats and prostate cancer risk has found what’s good for the heart may not be good for the prostate.

Nanomedicine closer to reality, Stanford

Stanford research moves nanomedicine one step closer to reality – A class of engineered nanoparticles — gold-centered spheres smaller than viruses — has been shown safe when administered by two alternative routes in a mouse study led by investigators at the Stanford University School of Medicine.

Acupuncture relieves hot flashes from prostate cancer treatment

Acupuncture relieves hot flashes from prostate cancer treatment – Acupuncture provides long-lasting relief to hot flashes, heart palpitations and anxiety due to side effects of the hormone given to counteract testosterone, the hormone that induces prostate cancer, according to a study published in the April issue of the International Journal of Radiation Oncology?Biology?Physics, an official journal of the American Society for Radiation Oncology (ASTRO).

Testosterone – prostate cancer link needs reevaluation

Study suggests another look at testosterone-prostate cancer link – The long-standing prohibition against testosterone therapy in men with untreated or low-risk prostate cancer merits reevaluation, according to a new study published in The Journal of Urology.

Closely monitoring better for low risk prostate cancer

Closely monitoring low-risk prostate cancer, with biopsy, does not raise risk of death and discourages overtreatment – A Johns Hopkins study of 769 men from across the United States recently diagnosed with low-grade prostate cancer shows that forgoing immediate surgery to remove the tumor or radiation poses no added risk of death.

Adoption of newer, more expensive prostate cancer treatments

Research shows rapid adoption of newer, more expensive prostate cancer treatments – With 180,000 men diagnosed with prostate cancer each year, it is one of the most common types of cancer in US. For this reason, it has been cited as a good marker for health care spending in general, reflective of the greater trends across the United States.

Gene based prostate cancer test may make more accurate treatment decisions

Researchers identify molecular predictor of metastatic prostate cancer — Finding lays the groundwork for gene-based test – Researchers conducted an elaborate series of experiments to identify the genes most closely linked to the aggressive biology of prostate cancer. They found about 300 genes that distinguished the two groups – indolent versus aggressive prostate cancers.

New drug approach for prostate cancer drug

MicroRNA suppresses prostate cancer stem cells and metastasis — UT MD Anderson preclinical research boosts case for new drug approach – A small slice of RNA inhibits prostate cancer metastasis by suppressing a surface protein commonly found on prostate cancer stem cells, revealed by researchers.

Incontinence after prostate surgery reduced with behavioral therapy

Behavioral therapy program reduces incontinence following radical prostatectomy – For men with incontinence for at least one year following radical prostatectomy, participation in a behavioral training program that included pelvic floor muscle training, bladder control strategies and fluid management, resulted in a significant reduction in the number of incontinence episodes.

Health Newstrack